Ligand Pharmaceuticals (LGND)
NASDAQ: LGND
· Real-Time Price · USD
152.81
-0.98 (-0.64%)
At close: Aug 15, 2025, 1:13 PM
Ligand Pharmaceuticals Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for LGND stock have an median target of 160, with a low estimate of 135 and a high estimate of 185. The median target predicts an increase of 4.71% from the current stock price of 152.81.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 135 | 157 | 160 | 185 |
| Change | -11.65% | 2.74% | 4.71% | 21.07% |
Latest Analyst Insight Report
Oppenheimer maintains an Outperform rating on Liga... Unlock content with Pro Subscription
Updated May 09, 2025
| Rating | Nov 24 | Dec 24 | Apr 25 | May 25 | Jul 25 | Aug 25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Buy | 4 | 4 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 4 | 1 | 1 | 1 | 1 |
Financial Forecast this Year
Revenue This Year
208.24M
from 167.13M
Increased by 24.6%
Revenue Next Year
239.8M
from 208.24M
Increased by 15.2%
EPS This Year
6.66
from -0.22
Increased by -2.93K%
EPS Next Year
7.16
from 6.66
Increased by 7.5%